DIA 2013 49th Annual Meeting
Click here to go to the previous page
Defining Clinical Trial Innovation: Challenges and Opportunities for 2013
Track
:
Track 19: Communities Showcase
Program Code:
145
Date:
Monday, June 24, 2013
Time:
2:30 PM to 4:00 PM
EST
Location:
204AB
CHAIR
:
Susan K Nunchuck, PhD,MSN (SCHNON), Senior Clinical Research Associate, Actelion Clinical Research, United States
SPEAKER
(S):
Craig H. Lipset, (SPKNON), Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc, United States Andreas Koester, MD,PhD (SPKNON), Vice President, Clinical Trial Innovation, External Alliances, Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Jeffrey S. Kasher, PhD (SPKNON), Vice President, Clinical Trial: Materials, Implementation and Transformation, Eli Lilly and Company, United States
Description
Innovation to improve global health and meet unmet medical needs has challenges and opportunities. Given the regulated and increasingly resource-constrained R&D environment, are there opportunities for innovation to ensure a sustainable future? Panelists will debate and discuss the issues in this interactive forum.
This forum has been developed by the Clinical Research Community.
This forum has been developed by the Clinical Research Community.
This session is a part of:
This session is a part of: